Highly Diluted Antibodies to eNOS Restore Endothelium Function in Aortic Rings From Hypertensive Rats.

Journal Information

Full Title: Dose Response

Abbreviation: Dose Response

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Radiology, Nuclear Medicine & Medical Imaging

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Declaration of Conflicting Interests: The authors declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: Sergey A. Tarasov, Nataliya V. Petrova and Oleg I. Epstein are employees of OOO “NPF “MATERIA MEDICA HOLDING” (partly). Oleg I. Epstein is a founder and a shareholder of OOO “NPF “MATERIA MEDICA HOLDING. OOO “NPF “MATERIA MEDICA HOLDING” sponsored the study, performed statistical analysis, made a decision to publish the work, and covered the current article processing charges, took part in the design of the experiments and the manuscript writing. HD Abs to eNOS is the substance (single, or one among other components) for commercial drugs Impaza, Divaza, Subetta, Afalaza produced by OOO “NPF “MATERIA MEDICA HOLDING”. Patents on this substance and the drugs belong either to OOO “NPF “MATERIA MEDICA HOLDING”, or Oleg I. Epstein. The authors have disclosed those interests fully to Dose-Response Journal."

Evidence found in paper:

"Funding: OOO “NPF “MATERIA MEDICA HOLDING” sponsored the study."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025